<DOC>
	<DOCNO>NCT00367835</DOCNO>
	<brief_summary>To assess efficacy safety SPD503 ( guanfacine hydrochloride ) subject ADHD oppositional symptom .</brief_summary>
	<brief_title>SPD503 ( Guanfacine Hydrochloride ) ADHD Plus Oppositional Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>Healthy subject ADHD oppositional symptom ADHDRS &gt; =24 CGI &gt; =4 Tscore Opp subscale CPRSR : L &gt; =65 Normal ECG BP &gt; = 55 lb</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>